Skip to content

Real world study for chemotherapy-related nausea and vomiting in cancer patients in Sichuan province

Real world study for chemotherapy-related nausea and vomiting in cancer patients in Sichuan province

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020386
Enrollment
Unknown
Registered
2018-12-27
Start date
2018-08-13
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

Patients with moderate to high emetogenic regimens:NA

Sponsors

Cancer Center, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as malignant tumor by pathology; 2. Receive chemotherapy regimen of moderate and high emetogenic: 3. Hematology, hepatorenal function and important organ function indicators meet the requirements of chemotherapy.

Exclusion criteria

Exclusion criteria: 1. Uncontrolled stable cancer pain and need to use or change opioid painkillers, or whose digestive tract reactions to opioid drugs have not been completely controlled; 2. Nausea and vomiting caused by any reason occurred within three days; 3. Patients who cannot read or complete the questionnaire independently; 4. With chronic digestive tract diseases history, chronic nausea and vomiting history (such as vertigo and meniere syndrome); 5. Patients with poor compliance and expected failure to complete the study as scheduled.

Design outcomes

Primary

MeasureTime frame
the proportion of patients with complete response;CINV outside risk period;

Countries

China

Contacts

Public Contactzhu Jiang

Cancer Center, West China Hospital, Sichuan University

hxnadal@163.com+86 18980602256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026